Clinical Trial Update: Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy, safety, and tolerability of a pioglitazone-azilsartan combination in adults with Type 2 diabetes mellitus; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Azilsartan (azilsartan)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes | Phase 3 | Status: TERMINATED